Calcium-activated potassium channel and connexin expression in small mesenteric arteries from eNOS-deficient (eNOS-/-) and eNOS-expressing (eNOS+/+) mice

European Journal of Pharmacology

Volumn 560, Issue 2-3, 2007, Pages 193-200

  Ceroni, Lisa ^a   Ellis, Anthie ^b   Wiehler, William B ^a   Jiang, Yan Fen ^a   Ding, Hong ^b   Triggle, Chris R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b RMIT University Bundoora West Campus   (Australia)

Author keywords

Calcium activated potassium channels; Connexin; EDHF (endothelium derived hyperpolarizing factor); eNOS; Nitric oxide; Small mesenteric arteries

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; APAMIN; BETA ACTIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CIRAZOLINE; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GAP JUNCTION PROTEIN; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; RHO FACTOR;

ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE EXPRESSION; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; BIOLOGICAL FACTORS; CONNEXINS; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RNA, MESSENGER; VASODILATION;

EID: 33847418275     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.018     Document Type: Article

References (48)

1. Bond C.T., Herson P.S., Strassmaier T., Hammond R., Stackman R., Maylie J., and Adelman J.P. Small conductance Ca2+-activated K+ channel knock-out mice reveal the identity of calcium-dependent after hyperpolarization currents. J. Neurosci. 24 (2004) 5301-5306
2. Bryan Jr. R.M., You J., Golding E.M., and Marrelli S.P. Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiology 102 (2005) 1261-1277
3. Burnham M.P., Bychkov R., Feletou M., Richards G.R., Vanhoutte P.M., Weston A.H., and Edwards G.. Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br. J. Pharmacol. 135 (2002) 1133-1143
4. Burnham M.P., Johnson I.T., and Weston A.H. Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in type II diabetic ZDF rats. Br. J. Pharmacol. 148 (2006) 434-441
5. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol. Sci. 23 (2002) 374-380
6. Bychkov R., Burnham M.P., Richards G.R., Edwards G., Weston A.H., Feletou M., and Vanhoutte P.M. Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br. J. Pharmacol. 137 (2002) 1346-1354
7. Coleman H.A., Tare M., and Parkington H.C. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin. Exp. Pharmacol. Physiol. 31 (2004) 641-649
8. Crane G.J., Gallagher N., Dora K.A., and Garland C.J. Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J. Physiol. 553 (2003) 183-189
9. De Vriese A.S., Verbeuren T.J., Van de Voorde J., Lameire N.H., and Vanhoutte P.M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130 (2000) 963-974
10. De Vriese A.S., Van de Voorde J., and Lameire N.H. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation. Kidney Int. 61 (2002) 177-185
11. de Wit C., Roos F., Bolz S.S., and Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol. Genomics 13 (2003) 169-177
12. Ding H., Kubes P., and Triggle C. Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 129 (2000) 1194-1200
13. Ding H., Hashem M., Wiehler W.B., Lau W., Martin J., Reid J., and Triggle C. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br. J. Pharmacol. 146 (2005) 1110-1118
14. Dora K.A., Sandow S.L., Gallagher N.T., Takano H., Rummery N.M., Hill C.E., and Garland C.J. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. J. Vasc. Res. 40 (2003) 480-490
15. Edwards G., Dora K.A., Gardener M.J., Garland C.J., and Weston A.H. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396 (1998) 269-272
16. Eichler I., Wibawa J., Grgic I., Knorr A., Brakemeier S., Pries A.R., Hoyer J., and Kohler R. Selective blockade of endothelial Ca(2+)-activated small- and intermediate-conductance K(+)-channels suppresses EDHF-mediated vasodilation. Br. J. Pharmacol. 138 (2003) 594-601
17. Feletou M., and Vanhoutte P.M. Endothelium-derived hyperpolarizing factor: where are we now?. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1215-1225
18. Garland C.J., and Plane F. Endothelium-derived Hyperpolarizing Factor (1996), Hardwood Academic Publishers 173-179
19. Goto K., Fujii K., Kansui Y., and Iida M. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors. Clin. Exp. Pharmacol. Physiol. 31 (2004) 650-655
20. Hilgers R.H., Todd Jr. J., and Webb R.C. Regional heterogeneity in acetylcholine-induced relaxation in rat vascular bed: role of calcium-activated K+ channels. Am. J. Physiol.: Heart Circ. Physiol. 291 (2006) H216-H222
21. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., and Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377 (1995) 239-242
22. Kusama N., Kajikuri J., Yamamoto T., Watanabe Y., Suzuki Y., Katsuya H., and Itoh T. Reduced hyperpolarization in endothelial cells of rabbit aortic valve following chronic nitroglycerine administration. Br. J. Pharmacol. 146 (2005) 487-497
23. Lang N.N., Luksha L., Newby D., and Kublickiene K. Connexin 43 mediates endothelium-derived hyperpolarising factor induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women. Am. J. Physiol.: Heart Circ. Physiol. (2006) Nov 3 [Electronic publication ahead of print]
24. Looft-Wilson R.C., Payne G.W., and Segal S.S. Connexin expression and conducted vasodilation along arteriolar endothelium in mouse skeletal muscle. J. Appl. Physiol. 97 (2004) 1152-1158
25. Marrelli S.P., Eckmann M.S., and Hunte M.S. Role of endothelial intermediate conductance KCa channels in cerebral EDHF-mediated dilations. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H1590-H1599
26. Mather S., Dora K.A., Sandow S.L., Winter P., and Garland C.J. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circ. Res. 97 (2005) 399-407
27. Matoba T., Shimokawa H., Nakashima M., Hirakawa Y., Mukai Y., Hirano K., Kanaide H., and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. 106 (2000) 1521-1530
28. McGuire J.J., Ding H., and Triggle C.R. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s). Can. J. Physiol. Pharm. 79 (2001) 443-470
29. McGuire J.J., Hollenberg M.D., Andrade-Gordon P., and Triggle C.R. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br. J. Pharmacol. 135 (2002) 155-169
30. McGuire J.J., Hollenberg M.D., Bennett B.M., and Triggle C.R. Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2. Can. J. Physiol. Pharm. 82 (2004) 1103-1112
31. McLenachan J.M., Vita J., Fish D.R., Treasure C.B., Cox D.A., Ganz P., and Selwyn A.P. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation 82 (1990) 1169-1173
32. Mullershausen F., Friebe A., Feil R., Thompson W.J., Hofmann F., and Koesling D. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. J. Cell Biol. 160 (2003) 719-727
33. Nagao T., Illiano S., and Vanhoutte P.M. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-l-arginine in rats. Am. J. Physiol. 263 (1992) H1090-H1094
34. Pannirselvam M., Simon V., Verma S., Anderson T., and Triggle C.R. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br. J. Pharmacol. 140 (2003) 701-706
35. Pannirselvam M., Ding H., Anderson T.J., and Triggle C.R. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur. J. Pharmacol. 551 1-3 (2006) 98-107
36. Parkington H.C., Tare M., Tonta M.A., and Coleman H.A. Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J. Physiol. 465 (1993) 459-476
37. Sandow S.L. Factors, fiction and endothelium-derived hyperpolarizing factor. Clin. Exp. Pharmacol. Physiol. 31 (2004) 563-570
38. Sandow S.L., and Hill C.E. Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ. Res. 86 (2000) 341-346
39. Sandow S.L., Looft-Wilson R., Doran B., Grayson T.H., Segal S.S., and Hill C.E. Expression of homocellular and heterocellular gap junctions in hamster arterioles and feed arteries. Cardiovasc. Res. 60 (2003) 643-653
40. Shimokawa H., Yasutake H., Fujii K., Owada M.K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., and Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J. Cardiovasc. Pharmacol. 28 (1996) 703-711
41. Taylor M.S., Bonev A.D., Gross T.P., Eckman D.M., Brayden J.E., Bond C.T., Adelman J.P., and Nelson M.T. Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ. Res. 93 (2003) 124-131
42. Triggle C.R., Howarth A., Cheng Z.J., and Ding H. Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes?. Can. J. Physiol. Pharm. 83 (2005) 681-700
43. Ujiie H., Chaytor A.T., Bakker L.M., and Griffith T.M. Essential role of Gap junctions in NO- and prostanoid-independent relaxations evoked by acetylcholine in rabbit intracerebral arteries. Stroke 34 (2003) 544-550
44. Vanhoutte P.M. Endothelium-dependent hyperpolarizations: the history. Pharmacol. Res. 49 (2004) 503-508
45. Villalobos C., Shakkottai V.G., Chandy K.G., Michelhaugh S.K., and Andrade R. SKCa channels mediate the medium but not the slow calcium-activated afterhyperpolarization in cortical neurons. J. Neurosci. 24 (2004) 3537-3542
46. von der Weid P.Y., and Coleman H.A. Reduced vascular reactivity after chronic nitroglycerine administration: EDHF mechanism is also downregulated. Br. J. Pharmacol. 146 (2005) 479-480
47. Waldron G.J., Ding H., Lovren F., Kubes P., and Triggle C.R. Acetylcholine-induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. Br. J. Pharmacol. 128 (1999) 653-658
48. Yamamoto T., Kajikuri J., Watanabe Y., Suzuki Y., Suzumori K., and Itoh T. Chronic nitroglycerine administration reduces endothelial nitric oxide production in rabbit mesenteric resistance artery. Br. J. Pharmacol. 146 (2005) 534-542